{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T18:51:33Z","timestamp":1781203893468,"version":"3.54.1"},"reference-count":96,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T00:00:00Z","timestamp":1689724800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Portuguesa de Cardiologia"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.repc.2023.04.013","type":"journal-article","created":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T03:02:25Z","timestamp":1689994945000},"page":"35-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Interventional cardiology in cancer patients: A position paper from the Portuguese Cardiovascular Intervention Association and the Portuguese Cardio-Oncology Study Group of the Portuguese Society of Cardiology"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8363-0363","authenticated-orcid":false,"given":"Miguel","family":"Nobre Menezes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7306-641X","authenticated-orcid":false,"given":"Marta","family":"Tavares da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4638-990X","authenticated-orcid":false,"given":"Andreia","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Melica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3386-2232","authenticated-orcid":false,"given":"J\u00falia Cristina","family":"Toste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6719-2065","authenticated-orcid":false,"given":"Rita","family":"Cal\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2179-4738","authenticated-orcid":false,"given":"Manuel","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7742-6195","authenticated-orcid":false,"given":"Manuela","family":"Fiuza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Infante de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.repc.2023.04.013_bib0485","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/eurheartj\/ehz859","article-title":"European Society of Cardiology: Cardiovascular Disease Statistics 2019","volume":"41","author":"Timmis","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2023.04.013_bib0490","series-title":"Programa Nacional para as Doen\u00e7as C\u00e9rebro-Cardiovasculares","author":"Ferreira","year":"2017"},{"key":"10.1016\/j.repc.2023.04.013_bib0495","first-page":"895","volume":"87","author":"Iliescu","year":"2016","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.repc.2023.04.013_bib0500","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.repc.2021.04.010","article-title":"Cancer patients with acute coronary syndrome have non-superior bleeding risk compared to patients with similar characteristics \u2013 a propensity score analysis from the ProACS registry","volume":"41","author":"Branco Mano","year":"2022","journal-title":"Rev Port Cardiol"},{"key":"10.1016\/j.repc.2023.04.013_bib0505","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2023.04.013_bib0510","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2023.04.013_bib0515","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2023.04.013_bib0520","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","volume":"42","author":"Collet","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2023.04.013_bib0525","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC)","volume":"41","author":"Neumann","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2023.04.013_bib0530","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/heartjnl-2020-318531","article-title":"Coronary revascularisation outcomes in patients with cancer","volume":"108","author":"Leedy","year":"2022","journal-title":"Heart"},{"key":"10.1016\/j.repc.2023.04.013_bib0535","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.repc.2023.04.013_bib0540","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2023.04.013_bib0545","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jaccao.2019.11.001","article-title":"Ischemia and bleeding in cancer patients undergoing percutaneous coronary intervention","volume":"1","author":"Ueki","year":"2019","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.repc.2023.04.013_bib0550","first-page":"631","article-title":"Prevalence and outcome of patients with cancer and acute coronary syndrome undergoing percutaneous coronary intervention: a BleeMACS substudy","volume":"7","author":"Iannaccone","year":"2018","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.repc.2023.04.013_bib0555","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s11936-018-0635-x","article-title":"Arterial thrombosis in patients with cancer","volume":"20","author":"Tuzovic","year":"2018","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"10.1016\/j.repc.2023.04.013_bib0560","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.jacc.2017.06.047","article-title":"Risk of arterial thromboembolism in patients with cancer","volume":"70","author":"Navi","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2023.04.013_bib0565","doi-asserted-by":"crossref","first-page":"e579","DOI":"10.1161\/CIR.0000000000000641","article-title":"Cardio-oncology: vascular and metabolic perspectives: a scientific statement from the American Heart Association","volume":"139","author":"Campia","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2023.04.013_bib0570","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","article-title":"2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines","volume":"37","author":"Zamorano","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2023.04.013_bib0575","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1161\/CIRCULATIONAHA.115.018347","article-title":"Vascular toxicities of cancer therapies","volume":"133","author":"Herrmann","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2023.04.013_bib0580","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40959-019-0048-3","article-title":"5-FU induced cardiotoxicity: case series and review of the literature","volume":"5","author":"Yuan","year":"2019","journal-title":"Cardio-Oncology"},{"key":"10.1016\/j.repc.2023.04.013_bib0585","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jaccao.2021.07.008","article-title":"Coronary artery disease in young women after radiation therapy for breast cancer: the WECARE study","volume":"3","author":"Carlson","year":"2021","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.repc.2023.04.013_bib0590","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/clc.22634","article-title":"Short and long term radiation induced cardiovascular disease in patients with cancer","volume":"40","author":"Nielsen","year":"2017","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.repc.2023.04.013_bib0595","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/j.mayocp.2020.05.044","article-title":"Coronary artery bypass grafting in cancer patients: prevalence and outcomes in the United States","volume":"95","author":"Guha","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.repc.2023.04.013_bib0600","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3389\/fcvm.2021.620857","article-title":"Machine learning-augmented propensity score analysis of percutaneous coronary intervention in over 30 million cancer and non-cancer patients","volume":"8","author":"Monlezun","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.repc.2023.04.013_bib0605","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/eurheartj\/ehy769","article-title":"Percutaneous coronary intervention in cancer patients: a report of the prevalence and outcomes in the United States","volume":"40","author":"Potts","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2023.04.013_bib0610","doi-asserted-by":"crossref","first-page":"e014383","DOI":"10.1161\/JAHA.119.014383","article-title":"Temporal trends in the prevalence of cancer and its impact on outcome in patients with first myocardial infarction: a nationwide study","volume":"9","author":"Velders","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.repc.2023.04.013_bib0615","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/eurheartj\/ehaa1032","article-title":"Percutaneous coronary intervention in patients with cancer and readmissions within 90 days for acute myocardial infarction and bleeding in the USA","volume":"42","author":"Kwok","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2023.04.013_bib0620","first-page":"53","article-title":"Percutaneous coronary intervention and in-hospital outcomes in patients with leukemia: a nationwide analysis","volume":"96","author":"Potts","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.repc.2023.04.013_bib0625","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/ehjqcco\/qcx047","article-title":"Outcome of current and history of cancer on the risk of cardiovascular events following percutaneous coronary intervention: a Kumamoto University Malignancy and Atherosclerosis (KUMA) study","volume":"4","author":"Tabata","year":"2018","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.repc.2023.04.013_bib0630","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.jcin.2014.05.035","article-title":"Outcomes after percutaneous coronary intervention with stents in patients treated with thoracic external beam radiation for cancer","volume":"7","author":"Liang","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.repc.2023.04.013_bib0635","doi-asserted-by":"crossref","first-page":"e003483","DOI":"10.1161\/CIRCINTERVENTIONS.115.003483","article-title":"Long-term mortality in patients with radiation-associated coronary artery disease treated with percutaneous coronary intervention","volume":"9","author":"Reed","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.repc.2023.04.013_bib0640","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1136\/heartjnl-2017-312123","article-title":"How to prevent and manage radiation-induced coronary artery disease","volume":"104","author":"Cuomo","year":"2018","journal-title":"Heart"},{"issue":"Supplement_4","key":"10.1016\/j.repc.2023.04.013_bib0645","doi-asserted-by":"crossref","first-page":"iv96","DOI":"10.1093\/annonc\/mdx758","article-title":"Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines","volume":"29","author":"Aapro","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.repc.2023.04.013_bib0650","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1016\/j.jacc.2012.06.017","article-title":"Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome","volume":"60","author":"Romagnoli","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2023.04.013_bib0655","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.jacc.2013.08.1651","article-title":"ST-segment elevation myocardial infarction treated by radial or femoral approach in a multicenter randomized clinical trial","volume":"63","author":"Bernat","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2023.04.013_bib0660","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.carrev.2021.08.024","article-title":"Ultrasound versus fluoroscopy-guided femoral access for percutaneous coronary intervention of chronic total occlusions: insights from FOUND BLOOD CTO Registry","volume":"38","author":"Piedimonte","year":"2022","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.repc.2023.04.013_bib0665","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/joic.12492","article-title":"Ultrasound guidance versus anatomical landmark approach for femoral artery access in coronary angiography: a randomized controlled trial and a meta-analysis","volume":"31","author":"Marquis-Gravel","year":"2018","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.repc.2023.04.013_bib0670","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1056\/NEJMoa1503943","article-title":"Polymer-free drug-coated coronary stents in patients at high bleeding risk","volume":"373","author":"Urban","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2023.04.013_bib0675","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jacc.2014.11.053","article-title":"Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates","volume":"65","author":"Valgimigli","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2023.04.013_bib0680","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1001\/jama.2019.8145","article-title":"Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving PCI","volume":"321","author":"Watanabe","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.repc.2023.04.013_bib0685","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1056\/NEJMoa2108749","article-title":"Dual antiplatelet therapy after PCI in patients at high bleeding risk","volume":"385","author":"Valgimigli","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2023.04.013_bib0690","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1016\/j.jcin.2017.06.068","article-title":"Re-evaluating the safety of drug-eluting stents in cancer patients","volume":"10","author":"Ganatra","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.repc.2023.04.013_bib0695","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1093\/eurheartj\/ehx512","article-title":"Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study","volume":"38","author":"Escaned","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2023.04.013_bib0700","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","article-title":"2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS","volume":"39","author":"Valgimigli","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2023.04.013_bib0705","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJMoa0807611","article-title":"Fractional flow reserve versus angiography for guiding percutaneous coronary intervention","volume":"360","author":"Tonino","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2023.04.013_bib0710","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1205361","article-title":"Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease","volume":"367","author":"De Bruyne","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2023.04.013_bib0715","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa1700445","article-title":"Use of the instantaneous wave-free ratio or fractional flow reserve in PCI","volume":"376","author":"Davies","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2023.04.013_bib0720","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa1616540","article-title":"Instantaneous wave-free ratio versus fractional flow reserve to guide PCI","volume":"376","author":"G\u00f6tberg","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2023.04.013_bib0725","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1161\/01.CIR.103.24.2928","article-title":"Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis","volume":"103","author":"Bech","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2023.04.013_bib0730","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jcin.2020.10.001","article-title":"3-Year outcomes of the ULTIMATE trial comparing intravascular ultrasound versus angiography-guided drug-eluting stent implantation","volume":"14","author":"Gao","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.repc.2023.04.013_bib0735","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jcin.2019.09.033","article-title":"Effect of intravascular ultrasound-guided drug-eluting stent implantation: 5-year follow-up of the IVUS-XPL randomized trial","volume":"13","author":"Hong","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.repc.2023.04.013_bib0740","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.4244\/EIJ-D-20-00498","article-title":"Outcomes of optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation: one-year results from the ILUMIEN III: OPTIMIZE PCI trial","volume":"16","author":"Ali","year":"2021","journal-title":"EuroIntervention"},{"key":"10.1016\/j.repc.2023.04.013_bib0745","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.jcin.2018.01.274","article-title":"Angiography alone versus angiography plus optical coherence tomography to guide percutaneous coronary intervention: outcomes from the Pan-London PCI Cohort","volume":"11","author":"Jones","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.repc.2023.04.013_bib0750","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.2016.3775","article-title":"Development and validation of a prediction rule for benefit and harm of dual antiplatelet therapy beyond 1 year after percutaneous coronary intervention","volume":"315","author":"Yeh","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.repc.2023.04.013_bib0755","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0140-6736(17)30397-5","article-title":"Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials","volume":"389","author":"Costa","year":"2017","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.repc.2023.04.013_bib0760","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1161\/CIRCULATIONAHA.108.828541","article-title":"Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction","volume":"119","author":"Subherwal","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2023.04.013_bib0765","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1093\/eurheartj\/ehz372","article-title":"Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk","volume":"40","author":"Urban","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2023.04.013_bib0770","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1001\/jama.2019.8146","article-title":"Effect of P2Y12 inhibitor monotherapy vs dual antiplatelet therapy on cardiovascular events in patients undergoing percutaneous coronary intervention","volume":"321","author":"Hahn","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.repc.2023.04.013_bib0775","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2023.04.013_bib0780","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2023.04.013_bib0785","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.4244\/EIJ-D-17-00634","article-title":"Clopidogrel or ticagrelor in acute coronary syndrome patients treated with newer-generation drug-eluting stents: CHANGE DAPT","volume":"13","author":"Zocca","year":"2017","journal-title":"EuroIntervention"},{"key":"10.1016\/j.repc.2023.04.013_bib0790","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa1708454","article-title":"Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation","volume":"377","author":"Cannon","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2023.04.013_bib0795","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0140-6736(19)31872-0","article-title":"Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial","volume":"394","author":"Vranckx","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.repc.2023.04.013_bib0800","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1817083","article-title":"Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation","volume":"380","author":"Lopes","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2023.04.013_bib0805","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1056\/NEJMoa1611594","article-title":"Prevention of bleeding in patients with atrial fibrillation undergoing PCI","volume":"375","author":"Gibson","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2023.04.013_bib0810","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(12)62177-1","article-title":"Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial","volume":"381","author":"Dewilde","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.repc.2023.04.013_bib0815","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1200\/JCO.2018.78.8034","article-title":"Comparison of an oral factor Xa inhibitor with low molecular weight heparin in patients with cancer with venous thromboembolism: results of a randomized trial (SELECT-D)","volume":"36","author":"Young","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.repc.2023.04.013_bib0820","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1056\/NEJMoa1711948","article-title":"Edoxaban for the treatment of cancer-associated venous thromboembolism","volume":"378","author":"Raskob","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2023.04.013_bib0825","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJMoa1915103","article-title":"Apixaban for the treatment of venous thromboembolism associated with cancer","volume":"382","author":"Agnelli","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2023.04.013_bib0830","doi-asserted-by":"crossref","first-page":"e001131","DOI":"10.1136\/openhrt-2019-001131","article-title":"Transcatheter aortic valve replacement in patients with severe aortic stenosis and active cancer: a systematic review and meta-analysis","volume":"7","author":"Bendary","year":"2020","journal-title":"Open Heart"},{"key":"10.1016\/j.repc.2023.04.013_bib0835","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jcmg.2015.06.028","article-title":"Valvular dysfunction in lymphoma survivors treated with autologous stem cell transplantation: a national cross-sectional study","volume":"9","author":"Murbraech","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.repc.2023.04.013_bib0840","doi-asserted-by":"crossref","first-page":"e005396","DOI":"10.1161\/JAHA.116.005396","article-title":"Long-term outcomes of patients with mediastinal radiation-associated severe aortic stenosis and subsequent surgical aortic valve replacement: a matched cohort study","volume":"6","author":"Donnellan","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.repc.2023.04.013_bib0845","first-page":"397","article-title":"Transcatheter compared with surgical aortic valve replacement in patients with previous chest-directed radiation therapy","volume":"3","author":"Farhang Yazdchi","year":"2021","journal-title":"Cardio Oncol"},{"key":"10.1016\/j.repc.2023.04.013_bib0850","first-page":"408","article-title":"Is TAVR preferred in patients with prior chest-directed radiation therapy?","volume":"3","author":"Tang","year":"2021","journal-title":"Cardio Oncol"},{"key":"10.1016\/j.repc.2023.04.013_bib0855","first-page":"e72","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2023.04.013_bib0860","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS Guidelines for the management of valvular heart disease. Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"43","author":"Vahanian","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2023.04.013_bib0865","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1056\/NEJMoa1400590","article-title":"Transcatheter aortic-valve replacement with a self-expanding prosthesis","volume":"370","author":"Adams","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2023.04.013_bib0870","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa1103510","article-title":"Transcatheter versus surgical aortic-valve replacement in high-risk patients","volume":"364","author":"Smith","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2023.04.013_bib0875","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1056\/NEJMoa1700456","article-title":"Surgical or transcatheter aortic-valve replacement in intermediate-risk patients","volume":"376","author":"Reardon","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2023.04.013_bib0880","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","article-title":"Transcatheter or surgical aortic-valve replacement in intermediate-risk patients","volume":"374","author":"Leon","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2023.04.013_bib0885","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa1816885","article-title":"Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients","volume":"380","author":"Popma","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2023.04.013_bib0890","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","article-title":"Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients","volume":"380","author":"Mack","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2023.04.013_bib0895","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijcard.2020.08.071","article-title":"Transcatheter and surgical aortic valve replacement impact on outcomes and cancer treatment schedule","volume":"326","author":"Gill","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.repc.2023.04.013_bib0900","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40959-021-00111-0","article-title":"TAVR and cancer: machine learning-augmented propensity score mortality and cost analysis in over 30 million patients","volume":"7","author":"Monlezun","year":"2021","journal-title":"Cardio-Oncology"},{"key":"10.1016\/j.repc.2023.04.013_bib0905","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3389\/fcvm.2021.641268","article-title":"TAVR in cancer patients: comprehensive review, meta-analysis, and meta-regression","volume":"8","author":"Marmagkiolis","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.repc.2023.04.013_bib0910","doi-asserted-by":"crossref","first-page":"e000855","DOI":"10.1136\/openhrt-2018-000855","article-title":"Incidental abnormal CT scan findings during transcatheter aortic valve implantation assessment: incidence and implications","volume":"5","author":"Patel","year":"2018","journal-title":"Open Heart"},{"key":"10.1016\/j.repc.2023.04.013_bib0915","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1009355","article-title":"Percutaneous repair or surgery for mitral regurgitation","volume":"364","author":"Feldman","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2023.04.013_bib0920","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1056\/NEJMoa1805374","article-title":"Percutaneous repair or medical treatment for secondary mitral regurgitation","volume":"379","author":"Obadia","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2023.04.013_bib0925","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","article-title":"Transcatheter mitral-valve repair in patients with heart failure","volume":"379","author":"Stone","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2023.04.013_bib0930","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s00392-020-01770-2","article-title":"Impact of cancer history on clinical outcome in patients undergoing transcatheter edge-to-edge mitral repair","volume":"110","author":"Tabata","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.repc.2023.04.013_bib0935","doi-asserted-by":"crossref","first-page":"7123607","DOI":"10.1155\/2018\/7123607","article-title":"Difference between the upper and the lower gastrointestinal bleeding in patients taking nonvitamin K oral anticoagulants","volume":"2018","author":"Maruyama","year":"2018","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.repc.2023.04.013_bib0940","doi-asserted-by":"crossref","first-page":"e006841","DOI":"10.1161\/CIRCEP.118.006841","article-title":"Evaluating real-world clinical outcomes in atrial fibrillation patients receiving the WATCHMAN left atrial appendage closure technology","volume":"12","author":"Boersma","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.repc.2023.04.013_bib0945","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"5-Year outcomes after left atrial appendage closure","volume":"70","author":"Reddy","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2023.04.013_bib0950","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2021.10.023","article-title":"4-Year outcomes after left atrial appendage closure versus nonwarfarin oral anticoagulation for atrial fibrillation","volume":"79","author":"Osmancik","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2023.04.013_bib0955","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.jcin.2019.04.002","article-title":"5-Year experience of in-hospital outcomes after percutaneous left atrial appendage closure in Germany","volume":"12","author":"Hobohm","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.repc.2023.04.013_bib0960","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.amjcard.2020.12.003","article-title":"Procedural and short-term outcomes of percutaneous left atrial appendage closure in patients with cancer","volume":"141","author":"Isogai","year":"2021","journal-title":"Am J Cardiol"}],"container-title":["Revista Portuguesa de Cardiologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0870255123003827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0870255123003827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:13:21Z","timestamp":1760109201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0870255123003827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":96,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0870255123003827"],"URL":"https:\/\/doi.org\/10.1016\/j.repc.2023.04.013","relation":{},"ISSN":["0870-2551"],"issn-type":[{"value":"0870-2551","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interventional cardiology in cancer patients: A position paper from the Portuguese Cardiovascular Intervention Association and the Portuguese Cardio-Oncology Study Group of the Portuguese Society of Cardiology","name":"articletitle","label":"Article Title"},{"value":"Revista Portuguesa de Cardiologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.repc.2023.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Sociedade Portuguesa de Cardiologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}